Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer’s disease
Martha Velueta-Viveros, Macarena Martínez‐Bailén, Adrián Puerta, Laura L. Romero-Hernández, Vladimı́r Křen, Penélope Merino‐Montiel, Sara Montiel‐Smith, Miguel X. Fernandes, Antonio J. Moreno‐Vargas, José M. Padrón, Óscar López, José G. Fernández‐Bolaños
Topics & Concepts
ChemistryAcetylcholineAcetylcholinesteraseBicyclic moleculeGalantamineStereochemistryRivastigmineHyperphosphorylationBiochemistryPharmacologyDonepezilPhosphorylationEnzymeDiseaseInternal medicineMedicineDementiaCholinesterase and Neurodegenerative DiseasesOrganoselenium and organotellurium chemistryEnzyme function and inhibition